Modified Factor VII

Details for Australian Patent Application No. 2004200261 (hide)

Owner Novo Nordisk A/S

Inventors Harta, Charles E.; Petersen, Lars Christian; Rasmussen, Mirella Ezban; Hedner, Ulla

Agent Spruson & Ferguson

Pub. Number AU-A-2004200261

Parent 766827

Filing date 23 January 2004

Wipo publication date 19 February 2004

International Classifications

A61K 038/36 Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

C07K 014/745 Peptides having more than 20 amino acids

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

Event Publications

12 February 2004 Complete Application Filed

19 February 2004 Application Open to Public Inspection

  Published as AU-A-2004200261

19 February 2004 Corrigenda

  Complete Applications Filed - Name Index under the name Novo Nordisk A/S, Application No. 2004200261, Under INID (31) correct the priority details to read 766827.

11 March 2004 Corrigenda

  Applications OPI - Name Index Under the name Novo Nordisk A/S, Application No. 2004200261, under INID (71) insert the name ZymoGenetics Inc.

26 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004200262-Well completion method and apparatus

2004200260-Method of Recovering Sulfur from Leaching Residue under Atmospheric Pressure